NDC 68180-602 – Lamivudine

Lamivudine 150 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC68180-602

Product details

Brand name
Lamivudine
Generic name
Lamivudine
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA205217
Marketed since
March 25, 2015
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Lamivudine →

Package NDC codes (0)

Package NDCDescriptionSince

Other Lamivudine products